CIK 0001006281
- Non-accelerated filer
- Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 650643773
- Phone
- +1 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Bar-Shalev Amos Director | Grant or award · Stock Options (Right to Buy) | +17,000 | 17,000 | ||
| 2026-09-03 | Bar-Shalev Amos Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2025-11-18 | Bar-Shalev Amos Director | Sale | −168 | $1.87 | $314 | 0 |
| 2025-09-03 | Bar-Shalev Amos Director | Grant or award | +7,500 | 7,500 | ||
| 2025-09-03 | Bar-Shalev Amos Director | Grant or award · Stock Options (Right to Buy) | +15,000 | 15,000 | ||
| 2023-09-29 | Bar-Shalev Amos Director | Grant or award · Stock Options (Right to Buy) | +61,676 | 61,676 | ||
| 2022-09-07 | Bar-Shalev Amos Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-20 | Bar-Shalev Amos Director | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | ||
| 2009-12-02 | Bar-Shalev Amos Director | Purchase | +1,000 | $8.68 | $9K | 1,000 |
| 2009-12-02 | Bar-Shalev Amos Director | Purchase | +680 | $8.20 | $6K | 1,680 |
| 2006-12-31 | Bar-Shalev Amos Director | Grant or award | +6,186,046 | 6,186,046 |
Page 1 of 1 · 11 trades